Literature DB >> 18384523

Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis.

Gaia Pocobelli1, Linda S Cook, Rollin Brant, Samuel S Lee.   

Abstract

BACKGROUND AND AIMS: We examined birth cohort and calendar period trends in hepatocellular carcinoma (HCC) incidence in Canada (1976-2000). We also projected HCC incidence rates through 2015. PATIENTS AND METHODS: Data were obtained from the Canadian Cancer Registry on all cases of HCC diagnosed among persons aged 20 years and older in Canada from 1976 to 2000 and was used to describe trends in HCC incidence rates.
RESULTS: We found that age-adjusted HCC incidence rates increased faster in males compared with females, 3.4% per year [95% confidence interval (CI): 3.0-3.8%] vs 2.2% per year (95% CI: 1.5-2.8%). An increasing birth cohort trend accelerated among males around the 1940 birth cohort and decelerated among females around the 1935 birth cohort. For calendar period trends, the increasing HCC risk was relatively constant over time among males whereas there was an acceleration in HCC risk around 1988 among females. Age-adjusted HCC incidence rates were projected to increase 73% in males and 28% in females from 1996 to 2015.
CONCLUSIONS: Our results suggest that HCC incidence rates will continue to increase in Canada during the next decade as persons born in more recent birth cohorts, who face a relatively greater risk for HCC, age.

Entities:  

Mesh:

Year:  2008        PMID: 18384523     DOI: 10.1111/j.1478-3231.2008.01704.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  20 in total

1.  Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.

Authors:  M Sherman; K Burak; J Maroun; P Metrakos; J J Knox; R P Myers; M Guindi; G Porter; J R Kachura; P Rasuli; S Gill; P Ghali; P Chaudhury; J Siddiqui; D Valenti; A Weiss; R Wong
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

2.  Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study.

Authors:  Hla-Hla Thein; Edwin Khoo; Michael A Campitelli; Ahmad Zaheen; Qilong Yi; Prithwish De; C C Earle
Journal:  CMAJ Open       Date:  2015-04-02

3.  Increasing incidence in liver cancer in Canada, 1972-2006: Age-period-cohort analysis.

Authors:  Xiaohong Jiang; Sai Yi Pan; Margaret de Groh; Shiliang Liu; Howard Morrison
Journal:  J Gastrointest Oncol       Date:  2011-12

4.  Prediction of cancer incidence in Tyrol/Austria for year of diagnosis 2020.

Authors:  Willi Oberaigner; Sabine Geiger-Gritsch
Journal:  Wien Klin Wochenschr       Date:  2014-09-06       Impact factor: 1.704

5.  Hepatocellular carcinoma in a large Canadian urban centre: stage at treatment and its potential determinants.

Authors:  Korosh Khalili; Ravi Menezes; Leyla Kochak Yazdi; Hyun-Jung Jang; Tae Kyoung Kim; Suraj Sharma; Jordan Feld; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-03

Review 6.  Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Davide Roccarina; Avik Majumdar; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10

7.  Prognosis in the early stages of hepatocellular carcinoma: Predicting outcomes and properly selecting patients for curative options.

Authors:  Kelly W Burak
Journal:  Can J Gastroenterol       Date:  2011-09       Impact factor: 3.522

Review 8.  An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm.

Authors:  Kelly W Burak; Norman M Kneteman
Journal:  Can J Gastroenterol       Date:  2010-11       Impact factor: 3.522

9.  Canadian trends in liver cancer: a brief clinical and epidemiologic overview.

Authors:  P De; D Dryer; M C Otterstatter; R Semenciw
Journal:  Curr Oncol       Date:  2013-02       Impact factor: 3.677

10.  Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study.

Authors:  H H Thein; Y Qiao; S K Young; W Zarin; E M Yoshida; C de Oliveira; C C Earle
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.